Absci Corporation (ABSI) Insider Trading
Insiders bought $933k on the open market and sold nothing.
Get an email when ABSI's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jun 30 | Mary T Szela Director | Bought | 12,900 | $11.54 | $149k | 154% | Form 4 |
| May 13 | Menelas N Pangalos Director | Bought | 37,453 | $5.36 | $201k | 19% | Form 4 |
| Mar 12 | Andreas Busch Chief Innovation Officer | Bought | 100,000 | $2.29 | $229k | 31% | Form 4 |
| Feb 27 | Menelas N Pangalos Director | Bought | 75,095 | $2.74 | $206k | 66% | Form 4 |
| Dec 5, 2025 | Frans Van Houten Director | Bought | 40,000 | $3.72 | $149k | 172% | Form 4 |
| Sep 22, 2025 | Menelas N Pangalos Director | Bought | 95,785 | $2.66 | $255k | 527% | Form 4 |
| Sep 22, 2025 | Todd Bedrick SVP, CAO | Bought | 10,000 | $2.70 | $27k | 5.9% | Form 4 |
| Jul 28, 2025 | Andreas Busch Chief Innovation Officer | Bought | 50,000 | $3.04 | $152k | 18% | Form 4 |
- Jun 30Mary T SzelaDirector · bought 12,900 at $11.54$149k154% of stake
- May 13Menelas N PangalosDirector · bought 37,453 at $5.36$201k19% of stake
- Mar 12Andreas BuschChief Innovation Officer · bought 100,000 at $2.29$229k31% of stake
- Feb 27Menelas N PangalosDirector · bought 75,095 at $2.74$206k66% of stake
- Dec 5, 2025Frans Van HoutenDirector · bought 40,000 at $3.72$149k172% of stake
- Sep 22, 2025Menelas N PangalosDirector · bought 95,785 at $2.66$255k527% of stake
- Sep 22, 2025Todd BedrickSVP, CAO · bought 10,000 at $2.70$27k5.9% of stake
- Jul 28, 2025Andreas BuschChief Innovation Officer · bought 50,000 at $3.04$152k18% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Related stocks: Services-Commercial Physical & Biological Research
Spot a number that looks wrong? Check it in ABSI's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ABSI
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.